| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.23 | 0.0007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.096 | 0.1 |